Reports First-Quarter Diluted EPS of $0.13 on a GAAP Basis, a Decrease of 94.8 Percent; Adjusted Diluted EPS of $2.46, a Decrease of 22.2 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share related to Acquired IPR&D and Milestones Expense Delivers First-Quarter Net…
Month: April 2023
YULIN, China, April 27, 2023 /PRNewswire/ — The intelligent mine solution powered by 5G and the industrial Internet that was jointly developed by Huawei and Shaanxi Coal Industry Co., Ltd. (Shaanxi Coal Company) hit its one-year milestone, marking a full year of continuous operations….
WARSAW, Ind., April 27, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at two upcoming healthcare conferences. The team will be presenting at…
ANNAPOLIS, Md., April 27, 2023 /PRNewswire/ — Alphyn Biologics, a clinical-stage dermatology company developing first-in-class multi-target therapeutics, will present for the first time new pediatric data from its Phase 2a clinical trial of a topical candidate for mild-to-moderate atopic…
2023 Aegis Virtual Conference, May 2-4 American Thoracic Society’s (ATS) 2023 Respiratory Innovation Summit (RIS), May 19-20 Yale Innovation Summit, May 31-June 1 NEW HAVEN, Conn., April 27, 2023 /PRNewswire/ — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical…
Multi-dwelling unit (MDU) property owners can realize increased net operating income (NOI) while improving Wi-Fi coverage with Cambium’s ONE Network solutions ROLLING MEADOWS, Ill., April 27, 2023 /PRNewswire/ — Cambium Networks (NASDAQ: CMBM), a leading global provider of networking…
Data from multiple studies of investigational bispecific drug zanidatamab, including pivotal Phase 2 biliary tract cancers (BTC) trial results, demonstrate breakthrough HER2-targeted pan-tumor potential Nine abstracts accepted for presentation, including two oral presentations, reinforce…
NEW YORK, April 27, 2023 /PRNewswire/ — M3-Brigade Acquisition III Corp. (NYSE: MBSC) (“MBSC” or the “Company”) announced today that its sponsor, M3-Brigade Sponsor III LP, or its affiliates or designees has deposited $1,696,500 into the Company’s trust account, in part from the…
NEW YORK, April 27, 2023 /PRNewswire/ — Hassenfeld Children’s Hospital at NYU Langone has recruited three internationally recognized physicians specialized in pediatric hepatology, delivering comprehensive, family-centered care to children and adolescents with acute and chronic liver…
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases. COLUMBIA, Md., April 27, 2023 /PRNewswire/ — The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for blinding…